IRCT201705261165N20招募中未知
therapeutic Effect and safety of squill oxymel in control of fatty liver disease in patients with mild to moderate fatty liver
Vice chancellor for research Baqiyatallah University of medical sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •To Sign the consent form Knowingly
- •patients be suffered from mild to moderate fatty liver According to the ultrasound result.
- •Exclusion criteria:
- •Off treatment for more than a week
- •Progression of Fatty liver disease
- •Person is pregnant or lactating
- •Allergic reactions to herbal blend
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Effect of Squill Oxymel in Treatment of Knee Arthrosisknee osteoarthritis.GonarthrosisIRCT2015101124474N1Traditional Medicine College of Shahid Beheshti University of Medical Sciences90
已完成
不适用
Evaluation of the effect of squill oxymel In asthmaAsthma.asthmaIRCT2014111119912N1College of Traditional Medicine of Tehran University of Medical Sciences51
已完成
不适用
Evaluation of the effect of squill oxymel In COPDchronic obstructive pulmonary disease (COPD).Chronic obstructive pulmonary disease, unspecifiedIRCT2016040919912N2Tehran University of Medical Sciences42
招募中
不适用
Clinical Efficacy and Safety Assessment of Oxaliplatin and Fluorouraciland, Leucovorin [modified FOLFOX6] in Combination with High-dose Bevacizumab as Second-line Therapy in Patients with Advanced or Recurrent Colorectal Cancer after Failure to Irinotecan. Multicenter Clinical Study.Patients with advanced or recurrent colorectal cancer after failure to Irinotecan.JPRN-UMIN000009748Third Department of Surgery,Tokyo Medical University70
进行中（未招募）
不适用
Safety and efficacy of a new solution, XyloCore, for peritoneal dialysisChronic kidney diseaseISRCTN16169961Sintesi Research170